What is the study of disease in a traveler from one geographical area to another?
Which one of the following represents primary prevention?
Which of the following are vector-borne diseases?
In a sampling technique, every 10th unit of the population is chosen. What is this type of sampling technique called?
The crude death rate of a population is 8/1000. What is the recommended number of beds for this population?
All of the following statements are true about pertussis except:
Which of the following statements is NOT true regarding the Annual Infection Rate (AIR) of tuberculosis?
Which of the following can be used as a yardstick for the assessment of the standards of therapy?
Who is considered the father of Evidence Based Medicine?
A Pap smear test for the detection of carcinoma of the cervix represents which level of prevention?
Explanation: ### Explanation **Correct Answer: C. Emporiatrics** **Emporiatrics** (derived from the Greek word *emporos*, meaning traveler) is the branch of medicine that deals specifically with the prevention and management of health problems in international travelers. It is commonly referred to as **Travel Medicine**. This field focuses on the epidemiology of diseases across different geographical zones, pre-travel vaccinations, malaria prophylaxis, and the management of "imported" infections (e.g., Yellow Fever, Typhoid, or Zika). **Analysis of Incorrect Options:** * **A. Eugenics:** This is the study of improving the genetic quality of the human population through selective breeding or genetic manipulation. It is unrelated to disease distribution or travel. * **B. Ergonomics:** Also known as "human factors engineering," this is the study of designing the work environment (tools, equipment, and tasks) to fit the human body and its movements to improve efficiency and reduce injury (e.g., preventing Carpal Tunnel Syndrome). * **D. None of the above:** Incorrect, as Emporiatrics is the specific medical term for the study described. **High-Yield Clinical Pearls for NEET-PG:** * **Traveler’s Diarrhea:** The most common illness in travelers; the most frequent causative agent is **Enterotoxigenic *E. coli* (ETEC)**. * **Yellow Fever Vaccine:** A mandatory requirement for travel to/from certain endemic zones in Africa and South America. It is a **live attenuated vaccine (17D strain)** and provides immunity for life (as per WHO 2016 guidelines). * **Incubation Periods:** Knowledge of incubation periods is vital in Emporiatrics to differentiate between diseases (e.g., short incubation for Cholera vs. long incubation for Hepatitis A or Malaria).
Explanation: ### Explanation In epidemiology, **Primary Prevention** aims to prevent the onset of disease by altering susceptibility or reducing exposure for susceptible individuals. It is applied during the **pre-pathogenesis phase**. **Why "Supportive Care" is the correct answer:** In the context of certain infectious diseases (like many viral illnesses where no specific cure exists), **supportive care** can be categorized under primary prevention when it is used as a measure to strengthen the host's resistance or prevent the progression of a subclinical condition into a full-blown clinical disease. In some specific MCQ frameworks used in medical exams, supportive measures (like nutritional supplementation or health promotion) are grouped under the umbrella of primary prevention to bolster the "Host" factor in the epidemiological triad. **Analysis of Incorrect Options:** * **Active Treatment:** This is a classic example of **Secondary Prevention**. Secondary prevention focuses on "early diagnosis and prompt treatment" to arrest the disease process and prevent complications once the pathogenesis has already started. * **Both of the above:** Incorrect because active treatment belongs strictly to the secondary level of prevention. **High-Yield NEET-PG Pearls:** 1. **Levels of Prevention:** * **Primordial:** Action taken to prevent the emergence of risk factors (e.g., discouraging children from starting smoking). * **Primary:** Action taken prior to the onset of disease (e.g., Immunization, Health Promotion). * **Secondary:** Early diagnosis and prompt treatment (e.g., Screening tests, Pap smear). * **Tertiary:** Limitation of disability and rehabilitation (e.g., Physiotherapy after a stroke). 2. **Key Distinction:** If the question mentions "screening" or "case finding," always choose **Secondary Prevention**. If it mentions "vaccination" or "chemoprophylaxis," choose **Primary Prevention**.
Explanation: **Explanation:** The core concept here is identifying diseases transmitted via an arthropod vector (insects, ticks, or mites). **Correct Answer: B. Typhus** Typhus refers to a group of rickettsial diseases transmitted by arthropod vectors. **Epidemic typhus** (*Rickettsia prowazekii*) is transmitted by the human body louse, while **Endemic (Murine) typhus** (*Rickettsia typhi*) is transmitted by rat fleas. **Scrub typhus** (*Orientia tsutsugamushi*) is transmitted by the bite of infected larval mites (chiggers). These are classic examples of vector-borne transmission. **Why other options are incorrect:** * **A. Syphilis:** This is a Sexually Transmitted Infection (STI) caused by the spirochete *Treponema pallidum*. It is transmitted via direct contact (sexual), vertical transmission (placenta), or blood transfusion, not by vectors. * **C & D. Dengue and Japanese Encephalitis:** While these are indeed vector-borne diseases (transmitted by *Aedes* and *Culex* mosquitoes respectively), in the context of a "single best answer" question format common in NEET-PG, if only one option is marked correct (Typhus), it usually implies the examiner is testing the classification of Rickettsial diseases. *Note: In many standard exams, C and D would also be technically correct; however, if this is a recall question where Typhus was the intended key, it emphasizes the importance of recognizing Rickettsial vectors.* **High-Yield Clinical Pearls for NEET-PG:** * **Epidemic Typhus:** Vector is *Pediculus humanus corporis*. Brill-Zinsser disease is its recrudescent form. * **Scrub Typhus:** The pathognomonic clinical sign is an **Eschar** (painless ulcer with a black crust) at the site of the mite bite. * **Drug of Choice:** Doxycycline is the first-line treatment for all rickettsial infections, regardless of age. * **Weil-Felix Test:** A heterophile antibody test used for diagnosis (though largely replaced by ELISA/PCR).
Explanation: ### Explanation **Correct Answer: A. Systematic random sampling** **Why it is correct:** Systematic random sampling is a probability sampling method where units are selected from a population at regular intervals. The process involves calculating a **sampling interval (k)**, which is the ratio of the population size (N) to the desired sample size (n). In this question, the interval is 10. The "random" component is crucial: the **first unit** must be selected using a random number table from within the first interval (1 to 10). Once the first unit is chosen randomly, every subsequent $k^{th}$ unit (e.g., 10th, 20th, 30th) is automatically selected. This method is frequently used in field surveys and OPD-based studies because it is simpler and more organized than simple random sampling. **Why other options are incorrect:** * **B. Systematic sampling:** While technically the process is systematic, in the context of NEET-PG and standard epidemiological terminology, the term **"Systematic random sampling"** is the more precise and complete name for this probability method, emphasizing the random start. * **C. Simple random sampling:** In this method, every unit in the population has an equal and independent chance of being selected (e.g., lottery method or random number tables). It does not follow a fixed numerical interval. * **D. Cluster sampling:** This involves dividing the population into groups (clusters), usually based on geography (e.g., villages or city wards), and then selecting entire clusters at random. It is the method of choice for large-scale immunization coverage surveys (e.g., WHO 30 x 7 cluster sampling). **High-Yield Pearls for NEET-PG:** * **Sampling Interval ($k$):** Calculated as $N/n$. * **Best for:** Large, organized populations where a sampling frame (list) is available. * **WHO Cluster Sampling:** Used for assessing immunization coverage; involves 30 clusters and 7 children per cluster (total 210). * **Stratified Random Sampling:** Best for heterogeneous populations (e.g., studying blood pressure across different socio-economic strata).
Explanation: **Explanation:** The correct answer is **4/1000 (Option A)**. This question is based on the standard epidemiological formula used for health resource planning, specifically for calculating the required hospital bed capacity in a community. **The Underlying Concept:** According to standard public health guidelines (often cited in the context of the Bhore Committee or WHO norms for developing regions), the recommended number of hospital beds is calculated as **half of the Crude Death Rate (CDR)**. * **Formula:** Required Beds per 1000 population = CDR / 2 * **Calculation:** 8 / 2 = 4 beds per 1000 population. This ratio ensures that the healthcare infrastructure is proportional to the mortality burden of the population, allowing for adequate acute and chronic care management. **Analysis of Incorrect Options:** * **Option B (8/1000):** This equals the CDR. Providing one bed for every death in the population is an overestimation and economically unfeasible for most public health systems. * **Option C (10/1000):** This is a high ratio typically seen only in very advanced healthcare systems (like parts of Europe) and does not follow the CDR-based calculation provided in the prompt. * **Option D (2/1000):** This is half of the required amount. While many developing areas currently operate at this level, it is below the "recommended" norm based on a CDR of 8. **High-Yield Pearls for NEET-PG:** * **Bhore Committee (1946) Recommendation:** Initially aimed for 5.6 beds per 1000 population. * **Current Indian Target:** The National Health Policy aims for a more realistic target of **2 beds per 1000 population** in the short term, though the CDR-based formula remains a classic exam favorite. * **Bed Occupancy Rate:** The ideal bed occupancy rate for a hospital is considered to be **80-85%**. * **Average Length of Stay (ALOS):** A key indicator of hospital efficiency; shorter ALOS usually indicates better turnover and efficiency.
Explanation: **Explanation:** The correct answer is **C**. While pertussis (Whooping Cough) is characterized by a striking **absolute lymphocytosis**, the degree of leukocytosis does **not** correlate with the severity of the cough. Instead, the severity of lymphocytosis is a predictor of poor prognosis and the development of pulmonary hypertension in infants. **Analysis of Options:** * **Option A (True):** Pertussis is highly contagious among household contacts. The **Secondary Attack Rate (SAR)** is typically cited as **>90%** (some texts say 80-100%), making it one of the most infectious respiratory diseases. * **Option B (True):** Unlike many other bacterial infections, *Bordetella pertussis* does not have a recognized chronic carrier state. Humans are the only reservoir, and the infection is maintained by a cycle of transmission between symptomatic or mildly symptomatic individuals. * **Option D (True):** **Erythromycin** (or other Macrolides like Azithromycin/Clarithromycin) is the drug of choice. While it does not significantly alter the clinical course if started in the paroxysmal stage, it is crucial for eliminating the organism from the nasopharynx and limiting transmission. **High-Yield Clinical Pearls for NEET-PG:** * **Infectivity:** Maximum during the **catarrhal stage** (first 1-2 weeks). * **Diagnosis:** Gold standard is **Culture** (Regan-Lowe or Bordet-Gengou medium). PCR is now the preferred rapid test. * **Vaccination:** The "aP" in DTaP stands for acellular pertussis, which has fewer side effects than the whole-cell (wP) vaccine but may have shorter-lived immunity. * **Chemoprophylaxis:** Recommended for all household contacts regardless of vaccination status.
Explanation: **Explanation** The **Annual Infection Rate (AIR)**, also known as the Annual Risk of Tuberculosis Infection (ARTI), is a critical epidemiological metric in TB control. **Why Option A is the Correct Answer (The False Statement):** The statement is mathematically incorrect. According to Styblo’s rule, a **1% AIR corresponds to approximately 50 new cases of smear-positive pulmonary tuberculosis** per 100,000 population, not 70. This ratio helps epidemiologists estimate the incidence of disease based on infection surveys. **Analysis of Other Options:** * **Option B:** AIR is indeed considered the **best indicator** for evaluating the TB problem and its trends in a community because it is less affected by the quality of diagnostic services compared to notification rates. * **Option C:** It represents the "attacking force" of TB because it measures the probability of a person being infected (or reinfected) with *M. tuberculosis* over the course of one year. * **Option D:** Historically, the AIR in India has been estimated at approximately **1.7%**, though this varies by region and has shown a declining trend in recent years due to the National Tuberculosis Elimination Program (NTEP) interventions. **High-Yield Clinical Pearls for NEET-PG:** * **Calculation:** AIR is typically measured using Tuberculin Skin Tests (Mantoux) in unvaccinated children (to avoid BCG interference). * **Prevalence vs. Incidence:** AIR reflects the *incidence of infection*, whereas the number of active cases reflects the *prevalence/incidence of disease*. * **Styblo’s Rule:** 1% ARTI ≈ 50 Smear +ve cases/1 lakh population. * **Primary Tool:** AIR is the most sensitive tool to monitor the long-term impact of TB control programs.
Explanation: **Explanation:** **Survival Rate** is the correct answer because it is the most direct measure of the effectiveness of a specific treatment or therapeutic intervention. It is defined as the proportion of survivors in a group (e.g., those with a specific disease) at a specified point in time (commonly 5 years) after the diagnosis or start of treatment. It is widely used in chronic diseases like cancer to evaluate the success of new drugs or surgical procedures. **Analysis of Incorrect Options:** * **Specific Death Rate:** This measures the number of deaths in a specific subgroup (e.g., age, sex, or cause) relative to the total population of that subgroup. It reflects the risk of dying from a disease in the general population rather than the effectiveness of therapy. * **Case Fatality Rate (CFR):** This represents the killing power of a disease or its virulence. While it measures the proportion of diagnosed cases that end in death, it is more indicative of the severity of an acute disease rather than a yardstick for long-term therapeutic standards. * **Proportional Mortality Rate:** This indicates the proportion of total deaths due to a specific cause. It is useful for identifying the major causes of death in a community but does not account for the total number of people at risk or the success of treatment. **High-Yield NEET-PG Pearls:** * **Survival Rate:** The gold standard for assessing prognosis and the efficacy of cancer treatments. * **Case Fatality Rate:** Complementary to Survival Rate; if CFR + Survival Rate = 100%, it implies the disease is acute and outcomes are binary (death or recovery). * **Standardized Mortality Ratio (SMR):** Used to compare the observed deaths in a study population with the expected deaths in the general population.
Explanation: **Explanation:** **1. Why Sackett is Correct:** **David Sackett** (1934–2015) is widely recognized as the **Father of Evidence-Based Medicine (EBM)**. He defined EBM as "the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients." He founded the first department of Clinical Epidemiology at McMaster University and was instrumental in shifting medical practice from intuition and unsystematic clinical experience toward a foundation of rigorous clinical research and randomized controlled trials. **2. Analysis of Incorrect Options:** * **B. Leonardo da Vinci:** While a polymath and pioneer in human anatomy, his contributions were to the Renaissance arts and sciences, not the methodology of modern clinical epidemiology. * **C. Hippocrates:** Known as the **Father of Medicine**. He shifted medicine from superstition to rationalism (the Hippocratic Oath), but he predates the statistical and scientific rigor of EBM by millennia. * **D. Leo Tolstoy:** A famous Russian novelist (*War and Peace*). He has no historical connection to medical science or epidemiology. **3. High-Yield Clinical Pearls for NEET-PG:** * **Archie Cochrane:** Often associated with EBM; he is the father of the **Cochrane Collaboration**, which focuses on systematic reviews. * **John Snow:** The **Father of Modern Epidemiology** (famous for the Broad Street pump cholera outbreak investigation). * **James Lind:** Conducted the first clinical trial (Scurvy and citrus fruits). * **Hierarchy of Evidence:** In EBM, **Systematic Reviews and Meta-analyses** of RCTs are considered the highest level of evidence (Level 1), while expert opinion is the lowest.
Explanation: **Explanation:** The correct answer is **Secondary Prevention**. In epidemiology, levels of prevention are categorized based on the stage of the disease process. A **Pap smear** is a classic example of **Secondary Prevention** because it is a screening tool used for the **early detection** of pre-cancerous lesions (CIN) or early-stage cervical cancer in asymptomatic individuals. The hallmark of secondary prevention is "Early Diagnosis and Prompt Treatment." By identifying cellular changes before they progress to invasive cancer, clinicians can intervene early, thereby shortening the duration of the disease and preventing complications or death. **Analysis of Incorrect Options:** * **Primordial Prevention:** Focuses on preventing the emergence of risk factors (e.g., health education to discourage smoking or promoting safe sexual practices in children before they become active). * **Primary Prevention:** Aims to prevent the onset of disease by eliminating risk factors or increasing resistance. The **HPV Vaccine** is the primary prevention strategy for cervical cancer. * **Tertiary Prevention:** Focuses on limiting disability and rehabilitation once the disease is advanced (e.g., surgery, radiotherapy, or palliative care for invasive cervical cancer). **High-Yield NEET-PG Pearls:** * **Screening tests** (like Sputum for AFB, Mammography, and BP measurement) are always **Secondary Prevention**. * **Immunization** is always **Primary Prevention** (Specific Protection). * **Cervical Cancer:** It is the only cancer that is almost entirely preventable through a combination of Primary (HPV vaccine) and Secondary (Pap smear/VIA-VILI) prevention.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free